Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leonel Reis da Silva Torrao
Observed names:
L Torrão,
L. Torrão,
Leonel Torrao,
Leonel Torrão
Institutions:
Novartis (Switzerland),
Novartis Institutes for BioMedical Research
Observed institutions:
Bial (Portugal),
Novartis (Switzerland),
Universidade do Porto,
Instituto de Biologia Molecular e Celular,
Novartis Institutes for BioMedical Research
ORCID:
0000-0001-9700-6879
Observed ORCID:
0000-0001-9700-6879
OpenAlex ID:
A5041648704
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
2010
·
László E. Kiss
, Humberto S. Ferreira
, et al.
·
Journal of Medicinal Chemistry
·
181
Programmed cell death induces male sterility in Actinidia deliciosa female flowers
2004
·
Sílvia Coimbra
, Leonel Torrão
, et al.
·
Plant Physiology and Biochemistry
·
64
Pharmacological profile of opicapone, a third‐generation nitrocatechol catechol‐ O ‐methyl transferase inhibitor, in the rat
2014
·
M J Bonifácio
, L Torrão
, et al.
·
British Journal of Pharmacology
·
59
Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor
2013
·
M.J. Bonifácio
, J.S. Sutcliffe
, et al.
·
Neuropharmacology
·
42
Design, synthesis, and structure–activity relationships of 1,3,4-oxadiazol-2(3H)-ones as novel FAAH inhibitors
2011
·
László E. Kiss
, Humberto S. Ferreira
, et al.
·
MedChemComm
·
31
Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection
2018
·
John Isbell
, Ding Yuan
, et al.
·
Journal of Pharmaceutical Sciences
·
26
Pharmacokinetic–Pharmacodynamic Interaction Between BIA 3-202, a Novel COMT Inhibitor, and Levodopa/Carbidopa
2004
·
Luis Almeida
, Manuel Vaz-da-Silva
, et al.
·
Clinical Neuropharmacology
·
16
2.243 Opicapone: Characterization of a Novel Peripheral Long-acting Catechol-o-methyltransferase Inhibitor
2011
·
M.J. Bonifacio
, L. Torrão
, et al.
·
Parkinsonism & Related Disorders
·
14
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
2009
·
Teresa Nunes
, Rita Machado
, et al.
·
Clinical Therapeutics
·
13
PDF
Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone
2009
·
Maria João Bonifácio
, Ana I. Loureiro
, et al.
·
Biochemical Pharmacology
·
11
2.242 Brain and Peripheral Levodopa Pharmacokinetics in the Cynomolgus Monkey Following Administration of Opicapone, a Novel Catechol-o-methyltransferase Inhibitor
2011
·
M.J. Bonifacio
, J.S. Sutcliffe
, et al.
·
Parkinsonism & Related Disorders
·
10
Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist
2020
·
Renata Murgasova
, Ester Tor Carreras
, et al.
·
Biopharmaceutics & Drug Disposition
·
7
Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic Impairment
2021
·
Jin Chen
, Jessie Gu
, et al.
·
The Journal of Clinical Pharmacology
·
4
Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility
2016
·
Alexandre Beliaev
, Humberto S. Ferreira
, et al.
·
Pure and Applied Chemistry
·
4
PDF
Pharmacological Profile of Opicapone in Wistar rat
2013
·
Maria João Bonifácio
, Leonel Torrão
, et al.
·
Elsevier eBooks
·
4
Chronopharmacology of nebicapone, a new catechol- O -methyltransferase inhibitor
2010
·
Luis Almeida
, Ana I. Loureiro
, et al.
·
Current Medical Research and Opinion
·
4
Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
2008
·
Manuel Vaz-da-Silva
, Ana I Loureiro
, et al.
·
Drugs in R&D
·
4
Effect of Opicapone, a New Catechol-O-Methyltransferase Inhibitor, in Levodopa Pharmakokinetics in the Cynomolgous Monkey
2013
·
Maria João Bonifácio
, Jane Suzanne Sutcliffe
, et al.
·
Elsevier eBooks
·
1
Membrane‐bound COMT inhibition by Nebicapone
2007
·
Maria Joao Bonifacio
, Leonel Torrão
, et al.
·
The FASEB Journal
·
1
Microsomal and hepatocyte binding in drug discovery: Method suitability and lipophilicity-based predictions
2026
·
Leonel Torrão
, Gaëlle Chenal
, et al.
·
Drug Metabolism and Pharmacokinetics
Poster Abstract #7: Pharmacokinetic-Pharmacodynamic Interaction Between Nebicapone (BIA 3-202) and Controlled-release Levodopa/Benserazide (Madopar HBS 125)
2008
·
Luis Almeida
, Jose Francisco Rocha
, et al.
·
Neurotherapeutics
Species‐differences in COMT inhibition by Nebicapone
2007
·
Maria Joao Bonifacio
, Leonel Torrao
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
22
Citation count:
496
H-index:
10
I10-index:
11
Year
Topic
Type